Role of Supplements and Parathyroid Hormone in Preventing Glucocorticoid-Induced Bone Loss

Inflammatory bowel disease, rheumatoid arthritis, asthma, and other conditions can all put patients at risk for glucocorticoid-induced osteoporosis (GIOP), a common and dangerous side effect of long-term glucocorticoid therapy. Although steroids, also known as glucocorticoids, help regulate immune reactions and inflammation, they can also lead to bone loss and increase the risk of fractures.